CUBE vs TVRD · P/E 25, rev $1.07B vs rev $7.1M
CubeSmart (CUBE) versus Tvardi Therapeutics, Inc. (TVRD) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported TVRD revenue for 2024-12-31 was $7.1M. Net income was -$70.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. TVRD currently screens at market cap $0.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. TVRD currently screens at market cap $0.
Not investment advice. Open the CUBE and TVRD stock pages for the full models.
Not investment advice.